Mostrar el registro sencillo del ítem

dc.contributor.authorGranados Santiago, María 
dc.contributor.authorValenza, Marie Carmen
dc.contributor.authorLópez López, Laura
dc.contributor.authorPrados Román, Esther
dc.contributor.authorRodríguez Torres, Janet
dc.contributor.authorCabrera Martos, Irene 
dc.date.accessioned2026-02-18T11:57:42Z
dc.date.available2026-02-18T11:57:42Z
dc.date.issued2020-04-02
dc.identifier.citationGranados-Santiago M, Valenza MC, Torres-Sánchez I, Cabrera-Martos I, López-Torres I, Moreno-Ramos MJ. Shared decision-making and patient engagement program during acute exacerbation of COPD hospitalization: A randomized control trial. Patient Educ Couns. 2020;103(4):702-708. doi:10.1016/j.pec.2019.12.004es_ES
dc.identifier.urihttps://hdl.handle.net/10481/111191
dc.description.abstractOBJECTIVE: To evaluate the effectiveness of a shared decision-making and patient engagement (SDM-PE) program concerning in-hospital stay during acute exacerbation of COPD and determine its impact on patients’ perceived health status. METHODS: Patients were randomly allocated to a control group that received standard treatment or an intervention group that received an individualized SDM-PE program in addition to standard treatment. The SDM-PE program included personalized health care focused on information about the disease, healthcare management, and reinforcement of behaviors regarding nutrition and exercise taking into account patients’ preferences. RESULTS: A comparative analysis between groups showed a significant improvement in perceived health status at discharge in patients included in the experimental group compared to those in the control group (60.28±21.65 vs. 54.13±22.69, p=0.036). In addition, perceived health status, COPD knowledge, adherence to pharmacological treatment, general functionality, and healthy lifestyle measures were significantly better at 3-month follow-up in the intervention group. CONCLUSION: An SDM-PE program significantly enhanced all the clinical measures assessed during hospitalization at 3-month follow-up. PRACTICE IMPLICATIONS: COPD patients and professionals need to work together to select the best care and treatment model for patients, taking into account individual values and preferences.es_ES
dc.description.sponsorshipThis research was financed jointly by Fundación Progreso y Salud (FPS), Boehringer Ingelheim España, S.A. (project code: PI-0370-2014), and Oximesa, Praxair. The authors JRT and LPP received financial support through grants for the training of university lecturers (grant numbers FPU: 16/01531 and FPU: 17/00408 respectively) of the Spanish Ministry of Education.es_ES
dc.language.isoenges_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPulmonary disease, chronic obstructivees_ES
dc.subjectdecision makinges_ES
dc.subjecthospital medicinees_ES
dc.subjectpatient participationes_ES
dc.titleShared decision-making and patient engagement program during acute exacerbation of COPD hospitalization: A randomized control triales_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doihttps://doi.org/10.1016/j.pec.2019.12.004
dc.type.hasVersionAMes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional